| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.00089 | 1 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.0049 | 1 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.00053 | 1 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.00043 | 1 |